Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1BNU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,597
Award facts
- Contract value 100% obligated
- $16,596.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,596.65 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300 mg pen auto-injectors in 2 ml formulations. This is a firm fixed price delivery order with no set-aside designation, issued on December 16, 2025, with an ultimate completion date of December 17, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026.
The IDC serves as a global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of medications and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. This specific delivery order for Cosentyx, a biologic immunosuppressant used to treat inflammatory conditions, represents a routine pharmaceutical procurement supporting Department of Defense medical supply requirements. AmerisourceBergen's federal contract portfolio demonstrates its significant role as a critical vendor for military and veteran healthcare systems, with consistent competitively awarded contracts reflecting the company's capability to meet federal procurement standards across diverse therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F1BNU?
SPE2DR26F1BNU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26F1BNU worth?
The government has obligated $16,597 on SPE2DR26F1BNU.
Is contract SPE2DR26F1BNU an order under another contract?
Yes. SPE2DR26F1BNU is a delivery order under SPE2DR25D2012, an indefinite delivery contract.
Was contract SPE2DR26F1BNU competed?
The extent of competition for SPE2DR26F1BNU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award